ProAssurance (NYSE:PRA) Announces Earnings Results

ProAssurance (NYSE:PRA) announced its quarterly earnings data on Monday. The insurance provider reported $0.36 EPS for the quarter, beating the consensus estimate of $0.17 by $0.19, Zacks reports. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%.

ProAssurance Price Performance

Shares of PRA traded up $0.03 during mid-day trading on Monday, hitting $14.02. 393,523 shares of the stock were exchanged, compared to its average volume of 186,591. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. The company has a market cap of $717.21 million, a PE ratio of 16.89 and a beta of 0.27. ProAssurance has a 52-week low of $10.76 and a 52-week high of $17.79. The firm has a 50-day moving average of $15.19 and a two-hundred day moving average of $15.01.

Wall Street Analysts Forecast Growth

PRA has been the subject of several recent analyst reports. Truist Financial upped their price target on ProAssurance from $14.00 to $18.00 and gave the stock a “hold” rating in a research note on Tuesday, November 12th. Piper Sandler lowered shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 target price for the company. in a research report on Monday, November 11th. Finally, StockNews.com raised shares of ProAssurance from a “hold” rating to a “buy” rating in a research note on Thursday, December 26th.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.